Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,otherCurrentAssets,changeToLiabilities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,investments,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,epsTrailingTwelveMonths,gmtOffSetMilliseconds,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,priceHint,shortName,longName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,exchange,market,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,esgPopulated,tradeable,exchangeDataDelayedBy,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,ISOLF,-414305.0,48891400,,,-970022,,-970022,1756214,489535,-855877,-855877,,-175777,,,,0,1324612,2180489,835077,-114145,,-970022,-970022,11442775.0,-414305.0,2397516.0,11028470.0,178320102.0,-182663334.0,3928927.0,2414600.0,239813.0,5766680.0,3928927.0,1897221.0,6716649.0,1266600.0,2179915.0,5219124.0,2557449.0,3166901.0,,-2668622.0,2071824.0,-63513.0,-297656.0,234143.0,172063.0,-1508984.0,3446122.0,-509088.0,,,,,949969.0,en-US,US,EQUITY,False,Delayed Quote,USD,-21.500008,0.0283 - 0.035325,0.045,0.0,0.0,0,0,finmb_404403312,Other OTC,CAD,24424,19949,0.024124999,2.154018,0.0112 - 0.27,-0.23467502,-0.86916673,0.0112,0.27,1532390400,-1.763,-14400000,-0.008,0.03911611,-0.0037911125,-0.09691946,0.058936294,-0.023611296,4,ISODIOL INTERNATIONAL INC,Isodiol International Inc.,0.035325,1630515336,-0.009675004,0.0283,0.035325,0.0283,7138,PRE,PNK,us_market,-0.40062404,1727088,-4.4156246,15,America/New_York,EDT,False,False,0,0.84,,,0.27,0.0112,0.0391,0.0589,24.42k,19.95k,48.89M,,44.38M,0.00%,1.29%,,,,,,,,,,,0.00%,"Jul 23, 2018",,1:10,"Jul 23, 2018","Mar 30, 2019","Dec 30, 2019",0.00%,-184.73%,-21.95%,-215.25%,15.79M,0.34,-85.70%,7.38M,-29.54M,-97.76M,-1.7630,,1.51M,0.03,5.85M,,1.16,-0.01,8.51M,-26.52M,Value,V6C 1S4,Healthcare,"Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.",Vancouver,604 409 4409,BC,1577750400,Canada,http://isodiol.com,86400,200 Granville Street,604 608 3348,Drug Manufacturers—Specialty & Generic,Suite 2710
t-1,ISOLF,626260.0,48891400,,,-3241110,,-3241110,2867432,403470,-3130646,-3130646,,-90241,,,,0,1878295,5008941,1474825,-110464,,-3241110,-3241110,14039748.0,626260.0,2374516.0,14666008.0,178275839.0,-181876162.0,4226583.0,2330600.0,303326.0,8456565.0,4226583.0,2069284.0,10266124.0,1266600.0,5126037.0,5126212.0,1048465.0,5899736.0,5126037.0,184091.0,191158.0,-2869745.0,307498.0,-3143774.0,172063.0,-35809.0,-1000565.0,586398.0,300000.0,-333469.0,-333469.0,,1809559.0,en-US,US,EQUITY,False,Delayed Quote,USD,-21.500008,0.0283 - 0.035325,0.045,0.0,0.0,0,0,finmb_404403312,Other OTC,CAD,24424,19949,0.024124999,2.154018,0.0112 - 0.27,-0.23467502,-0.86916673,0.0112,0.27,1532390400,-1.763,-14400000,-0.008,0.03911611,-0.0037911125,-0.09691946,0.058936294,-0.023611296,4,ISODIOL INTERNATIONAL INC,Isodiol International Inc.,0.035325,1630515336,-0.009675004,0.0283,0.035325,0.0283,7138,PRE,PNK,us_market,-0.40062404,1727088,-4.4156246,15,America/New_York,EDT,False,False,0,0.84,,,0.27,0.0112,0.0391,0.0589,24.42k,19.95k,48.89M,,44.38M,0.00%,1.29%,,,,,,,,,,,0.00%,"Jul 23, 2018",,1:10,"Jul 23, 2018","Mar 30, 2019","Dec 30, 2019",0.00%,-184.73%,-21.95%,-215.25%,15.79M,0.34,-85.70%,7.38M,-29.54M,-97.76M,-1.7630,,1.51M,0.03,5.85M,,1.16,-0.01,8.51M,-26.52M,Value,V6C 1S4,Healthcare,"Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.",Vancouver,604 409 4409,BC,1577750400,Canada,http://isodiol.com,86400,200 Granville Street,604 608 3348,Drug Manufacturers—Specialty & Generic,Suite 2710
t-2,ISOLF,3559872.0,48891400,,,-2825092,,-2825092,3242820,1077389,-2786629,-2786629,,-89862,,,,0,4219571,7006200,3142182,-38463,,-2825092,-2825092,14096214.0,3559872.0,2360670.0,17656086.0,178275839.0,-178635052.0,3919085.0,2246600.0,3173071.0,8357380.0,3919085.0,2241347.0,13168139.0,1266600.0,5002958.0,5281863.0,1012656.0,5741991.0,,793611.0,-1165934.0,2769257.0,-1171341.0,5525018.0,172063.0,-154016.0,8149582.0,554804.0,1421420.0,-3005840.0,-3005840.0,1203420.0,4810759.0,en-US,US,EQUITY,False,Delayed Quote,USD,-21.500008,0.0283 - 0.035325,0.045,0.0,0.0,0,0,finmb_404403312,Other OTC,CAD,24424,19949,0.024124999,2.154018,0.0112 - 0.27,-0.23467502,-0.86916673,0.0112,0.27,1532390400,-1.763,-14400000,-0.008,0.03911611,-0.0037911125,-0.09691946,0.058936294,-0.023611296,4,ISODIOL INTERNATIONAL INC,Isodiol International Inc.,0.035325,1630515336,-0.009675004,0.0283,0.035325,0.0283,7138,PRE,PNK,us_market,-0.40062404,1727088,-4.4156246,15,America/New_York,EDT,False,False,0,0.84,,,0.27,0.0112,0.0391,0.0589,24.42k,19.95k,48.89M,,44.38M,0.00%,1.29%,,,,,,,,,,,0.00%,"Jul 23, 2018",,1:10,"Jul 23, 2018","Mar 30, 2019","Dec 30, 2019",0.00%,-184.73%,-21.95%,-215.25%,15.79M,0.34,-85.70%,7.38M,-29.54M,-97.76M,-1.7630,,1.51M,0.03,5.85M,,1.16,-0.01,8.51M,-26.52M,Value,V6C 1S4,Healthcare,"Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.",Vancouver,604 409 4409,BC,1577750400,Canada,http://isodiol.com,86400,200 Granville Street,604 608 3348,Drug Manufacturers—Specialty & Generic,Suite 2710
t-3,ISOLF,6932898.0,48891400,,,-2825092,,0,3242820,0,0,-2786629,,-89862,,,,0,0,0,0,0,,-2825092,-2825092,16685075.0,6932898.0,3052588.0,23617973.0,176979582.0,-175809960.0,5763276.0,2162600.0,403814.0,11495115.0,5763276.0,1616814.0,19838559.0,2470020.0,13902540.0,5189960.0,858640.0,5475439.0,,0.0,-1165934.0,2769257.0,-1171341.0,5525018.0,172063.0,-154016.0,8149582.0,554804.0,1421420.0,-3005840.0,-3005840.0,1203420.0,8343444.0,en-US,US,EQUITY,False,Delayed Quote,USD,-21.500008,0.0283 - 0.035325,0.045,0.0,0.0,0,0,finmb_404403312,Other OTC,CAD,24424,19949,0.024124999,2.154018,0.0112 - 0.27,-0.23467502,-0.86916673,0.0112,0.27,1532390400,-1.763,-14400000,-0.008,0.03911611,-0.0037911125,-0.09691946,0.058936294,-0.023611296,4,ISODIOL INTERNATIONAL INC,Isodiol International Inc.,0.035325,1630515336,-0.009675004,0.0283,0.035325,0.0283,7138,PRE,PNK,us_market,-0.40062404,1727088,-4.4156246,15,America/New_York,EDT,False,False,0,0.84,,,0.27,0.0112,0.0391,0.0589,24.42k,19.95k,48.89M,,44.38M,0.00%,1.29%,,,,,,,,,,,0.00%,"Jul 23, 2018",,1:10,"Jul 23, 2018","Mar 30, 2019","Dec 30, 2019",0.00%,-184.73%,-21.95%,-215.25%,15.79M,0.34,-85.70%,7.38M,-29.54M,-97.76M,-1.7630,,1.51M,0.03,5.85M,,1.16,-0.01,8.51M,-26.52M,Value,V6C 1S4,Healthcare,"Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.",Vancouver,604 409 4409,BC,1577750400,Canada,http://isodiol.com,86400,200 Granville Street,604 608 3348,Drug Manufacturers—Specialty & Generic,Suite 2710
